Morphological and functional changes in multifocal vitelliform retinopathy and biallelic mutations in BEST1

Ophthalmic Genetics

Volumn 32, Issue 2, 2011, Pages 83-96

  Wittström, Elisabeth ^a   Ekvall, Sara ^b   Schatz, Patrik ^a   Bondeson, Marie Louise ^b   Ponjavic, Vesna ^a   Andréasson, Sten ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

BEST1; biallelic mutations; multifocal BVMD

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ARTICLE; BEST1 GENE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; DNA SEQUENCE; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NUCLEOTIDE SEQUENCE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA VITELLIFORM DEGENERATION; SUBRETINAL FLUID;

ADOLESCENT; CHLORIDE CHANNELS; DNA MUTATIONAL ANALYSIS; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; PEDIGREE; PHENOTYPE; RETINA; SEQUENCE ANALYSIS, DNA; TOMOGRAPHY, OPTICAL COHERENCE; VITELLIFORM MACULAR DYSTROPHY;

EID: 79955847261     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.535890     Document Type: Article

References (67)

1. Petrukhin K, Koisti MJ, Bakall B, et al. Identifcation of the gene responsible for Best macular dystrophy. Nat Genet.1998;19:241-247. (Pubitemid 28309334)
2. Marmorstein AD, Marmorstein LY, Rayborn M, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA. 2000;97:12758-12763.
3. Marquardt A, Stöhr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown prop-erties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet.1998;7:1517-1525. (Pubitemid 28429935)
4. Ponjavic V, Eksandh L, Andreasson S, et al. Clinical expres-sion of Best's vitelliform macular dystrophy in Swedish families with mutations in the bestrophin gene. Ophthalmic Genet. 1999;20:251-257. (Pubitemid 30088705)
5. Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein-functional implications. Hum Genet. 1999;104:383-389. (Pubitemid 29286794)
6. Allikmets R, Seddon JM, Bernstein PS, et al. Evaluation of the Best disease gene in patients with age-related macu-lar degeneration and other maculopathies. Hum Genet. 1999;104:449-453. (Pubitemid 29370918)
7. Lotery AJ, Munier FL, Fishman GA, et al. Allelic varia-tion in the VMD2 gene in Best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:1291-1296. (Pubitemid 30261849)
8. White K, Marquardt A, Weber BH. VMD2 mutations in vitel-liform macular dystrophy (Best disease) and other macul-opathies. Hum Mutat. 2000;15:301-308. (Pubitemid 30194719)
9. Eksandh L, Bakall B, Bauer B, et al. Best's vitelliform macu-lar dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene. Ophthalmic Genet. 2001;22:107-115. (Pubitemid 32881497)
10. Krämer F, Mohr N, Kellner U, et al. Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD). Hum Mutat. 2003;22:418.
11. Apushkin MA, Fishman GA, Taylor CM, et al. Novel de novo mutation in a patient with Best macular dystrophy. Arch Ophthalmol. 2006;124:887-889. (Pubitemid 43877684)
12. Schatz P, Klar J, Andreasson S, et al. Variat phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2. Ophthalmic Genet. 2006;27:51-56. (Pubitemid 43879985)
13. Wabbels B, Preising MN, Kretschmann U, et al. Genotype-phenotype correlation and longitudinal course in ten fami¬lies with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1453-1466. (Pubitemid 44741257)
14. Marchant D, Yu K, Bigot K, et al. New VMD2 gene muta-tions identifed in patients affected by Best vitelliform macu-lar dystrophy. J Med Genet. 2007;44,e70.
15. Testa F, Rossi S, Passerini I, et al. A normal electro-oculography in a family affected by Best disease with a novel spontaneous mutation of the BEST1 gene. Br J Ophthalmol. 2008;92:1467-1470.
16. Sohn EH, Francis PJ, Duncan JL, et al. Phenotypic variability due to a novel glu292lys variation in exon 8 of the BEST1 gene causing Best macular dystrophy. Arch Ophthalmol. 2009;127: 913-920.
17. Boon CJ, Theelen T, Hoefsloot EH, et al. Clinical and molec-ular genetic analysis of Best vitelliform macular dystrophy. Retina. 2009;29:835-847.
18. Boon CJ, Klevering BJ, Leroy BP, et al. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retinal Eye Res. 2009;28:187-205.
19. Krämer F, Whie K, Pauleikhoff D, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform mac-ular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000;8:286-292. (Pubitemid 30336182)
20. Boulton M, Dayhaw-Barker P. The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye. 2001;15:384-389. (Pubitemid 32600862)
21. Sun H, Tsunenari T, Yau KW, et al. The vitelliform macular dystrophy protein defnes a new family of chloride chan-nels. Proc Natl Acad Sci USA. 2002;99:4008-4013. (Pubitemid 34252220)
22. Yu K, Cui Y, Hartzell C. The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function. Invest Ophthalmol Vis Sci. 2006;47: 4956-4961. (Pubitemid 46586399)
23. Tsunenari T, Sun H, Williams J, et al. Structure-function analysis of the bestrophin family of anion channels. J Biol Chem. 2003;278:41114-41125. (Pubitemid 37280936)
24. Chien LT, Hartzell HC. Drosophila bestrophin-1 chloride current is dually regulated by calcium and cell volume. J Gen Physiol. 2007;130: 513-524. (Pubitemid 350036737)
25. Kunzelmann K, Milenkovic VM, Spitzner M, et al. Calcium-dependent- chloride conductance in epithelia: is there a con-tribution by bestrophin? Eur J Physiol. 2007;454:879-889.
26. Milenkovic VM, Rivera A, Horling F, et al. Insertion and topology of normal and mutant bestrophin-1 in the endo-plasmic reticulum membrane. J Biol Chem. 2007;282: 1313-1321. (Pubitemid 47076533)
27. Spaide RF, Noble K, Morgan A, et al. Vitelliform macular dystrophy. Ophthalmology. 2006;113:1392-1400.
28. Hartzell C, Qu Z, Yu K, et al. Molecular physiology of bestrophins: Multifunctional membrane proteins linked to Best disease and other retinopathies. Physiol Rev. 2008;88:639-672. (Pubitemid 351522747)
29. Marmorstein LY, Wu J, McLaughlin P, et al. The light peak of the electroretinogram is dependent on voltage-gated cal-cium channels and antagonized by bestrophin(Best-1). J Gen Physiol. 2006;127:577-589.
30. Rosenthal R, Bakall B, Kinnick T, et al. Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epi-thelial cells. FASEB J. 2006;20:178-180. (Pubitemid 43100506)
31. Marmorstein AD, Kinnick TR. Focus on molecules: bestro-phin (Best-1). Exp Eye Res. 2007;85:423-424.
32. Marmorstein AD, Cross HE, Peachey NS. Functional roles of bestrophins in ocular epithelia. Prog Retin Res. 2009;28:206-226.
33. Wu J, Marmorstein AD, Striessnig J, et al. Voltage-dependent calcium channel CaV 1,3 subunits regulate the light peak of the electroretinogram. J Neurophysiol. 2007;97:3731-3735. (Pubitemid 47084784)
34. Cross HE, Bard L. Electro-oculography in Best's macular dystrophy. Am J Ophthalmol. 1974;77:46-50.
35. Renner AB, Tillack H, Kraus H, et al. Late onset is com-mon in Best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005;112:586-592. (Pubitemid 41108857)
36. Renner AB, Tillack H, Kraus H, et al. Morphology and func¬tional characteristics in adult vitelliform macular dystrophy. Retina. 2004; 24: 929-939. (Pubitemid 39657491)
37. Seddon JM, Afshari MA, Sharma S, et al. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystro-phy, age-related maculopathy, and bull's eye maculopathy. Ophthalmology. 2001;108:2060-2067. (Pubitemid 33032779)
38. Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophtalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45:3683-3689. (Pubitemid 39302642)
39. Burgess R, MacLaren RE, Davidson AE, et al. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009;46: 620-625.
40. Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82:19-31. (Pubitemid 351726077)
41. Davidson AE, Millar ID, Urquhart JE, et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009;85:581-92.
42. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1115-1121. (Pubitemid 12078139)
43. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1108-1114. (Pubitemid 12078138)
44. O'gorman S, Flaherty WA, Fishman GA, et al. Histopathologic fndings in Best's vitelliform macular dys-trophy. Arch Ophthalmol. 1988;106:1261-8.
45. Mullins RF, Oh KT, Heffron E, et al. Late development of vitelliform lesions and fecks in a patient with Best disease: clinicopathologic correlation. Arch Ophthalmol. 2005: 123: 1588-1594. (Pubitemid 41626697)
46. Bakall B, Radu RA, Stanton JB, et al. Enhanced accumula-tion of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res. 2007;85: 34-43. (Pubitemid 47017265)
47. Mohler CW, Fine SL. Long-term evaluation of patients with Best́s vitelliform dystrophy. Ophthalmology. 1981;88:688-692. (Pubitemid 11087734)
48. Boon CJ, Klevering BJ, den Hollander AI, et al. Clinical and genetic heterogeneity in multifocal vitelliform dystrophy. Arch Ophthalmol. 2007;125:1100-1106. (Pubitemid 47258041)
49. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol. 1977;95:984-990. (Pubitemid 8172223)
50. Guziewicz KE, Zangerl B, Lindauer SJ, et al. Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for Best disease. Invest Ophthalmol Vis Sci. 2007;48:1959-1967. (Pubitemid 351261261)
51. Marmor MF, Holder GE, Seeliger MV, et al. Standard for clini-cal electroretinography. Doc Ophthalmol. 2004;108:107-114.
52. Brown M, Marmor M, Vaegan, Zrenner E, et al. ISCEV standard for clinical electro-oculography (EOG). Doc Ophthalmol. 2006;113:205-212. (Pubitemid 44835005)
53. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography. Doc Ophthalmol. 2008;116:1-11.
54. Best F. Über eine hereditäre Maculaaffektion: Beitrag zur Vererbungslehre. Z Augenheilkd. 1905;13:199-212.
55. Seddon JM, Sharma S, Chong S, et al. Phenotype and geno-type correlations in two best families. Ophthalmology. 2003;110:1724-1731. (Pubitemid 37025430)
56. Nordström S, Thorburn W. Dominantly inherited macular degeneration (Best́s disease) in a homozygous father with 11 children. Clin Genet. 1980;18:211-216. (Pubitemid 10004838)
57. Glybina I V, Frank RN. Localization of multifocal elec-troretinogram abnormalities to the lesion site: fndings in a family with Best disease. Arch Ophthalmol. 2006;124:1593-1600. (Pubitemid 44748734)
58. Gerth C, Zawadzki RJ, Werner JS, et al. Detailed analysis of retinal function and morphology in a patient with auto-somal recessive bestrophinopathy (ARB). Doc Ophthalmol. 2009;118:239-246.
59. Palmowski AM, Allgayer R, Heinemann-Vernaleken B, et al. Detection of retinal dysfunction in vitelliform macu-lar dystrophy using the multifocal ERG (MF-ERG). Doc Ophthalmol. 2003;106:145-152. (Pubitemid 36355956)
60. Schatz P, Bitner H, Sander B, et al. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1. Invest Ophthalmol Vis Sci. 2010;51:4754-4765.
61. Pianta MJ, Aleman TS, Cideciyan AV, et al. In vivo micropa-thology of Best macular dystrophy with optical coherence tomography. Exp Eye Res. 2003;76:203-211. (Pubitemid 36263346)
62. Saito W, Yamamoto S, Hayashi M, et al. Morphological and functional analyses of adult onset vitelliform macular dys-trophy. Br J Ophthalmol. 2003;87:758-762. (Pubitemid 36649231)
63. Benhamou N, Messas-Kaplan A, Cohen Y, et al. Adult-onset foveomacular vitelliform dystrophy with OCT3. Am J Ophthalmol. 2004;138:294-296. (Pubitemid 39037439)
64. Vedantham V, Ramasamy K. Optical coherence tomogra¬phy in Best's disease: an observational case report. Am J Ophthalmol. 2005; 139:351-353. (Pubitemid 40288287)
65. Querques G, Bux AV, Prato R, et al. Correlation of visual function impairment and optical coherence tomography fndings in patients with adult-onset foveomacular vitel-liform macular dystrophy. Am J Ophthalmol. 2008;146: 135-142.e2
66. Querques G, Regenbogen M, Quijano C, et al. High-defnition optical coherence tomography features in vitelliform macu-lar dystrophy. Am J Ophthalmol. 2008;146:501-507.e1
67. Park DW, Polk TD, Stone EM. Fluctuating vision in Best disease. Arch Ophthalmol. 1997;115:1469-1470.